Gemcitabine in cervical cancer
Authors:
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 90 (2) , S8-S15
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinomaCancer, 2002
- Phase II Study of Concurrent Gemcitabine and Radiotherapy in Locally Advanced Stage IIIB Cervical CarcinomaGynecologic Oncology, 2001
- A phase I–II study of weekly cisplatin (C) and gemcitabine (G) with concurrent radiotherapy (R) in locally advanced cervical cancer (LACC)European Journal of Cancer, 2001
- Weekly Cisplatin/Low-Dose Gemcitabine Combination for Advanced and Recurrent Cervical CarcinomaAmerican Journal of Clinical Oncology, 2001
- Gemcitabine Is Ineffective in Recurrent, Preirradiated Cervical Cancer: To the EditorGynecologic Oncology, 2000
- Evaluation of Gemcitabine in Patients with Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology GroupGynecologic Oncology, 2000
- A Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced, Persistent, or Recurrent Squamous Cell Carcinoma of the CervixGynecologic Oncology, 2000
- Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical CarcinomaNew England Journal of Medicine, 1999
- 1180 A phase II study of gemcitabine in advanced cervix carcinomaEuropean Journal of Cancer, 1995
- A Phase II Trial of Neoadjuvant Chemotherapy Prior to Radical Hysterectomy and/or Radiation Therapy in the Management of Advanced Carcinoma of the Uterine CervixGynecologic Oncology, 1995